Effect of Acyclovir on HIV-1 Set Point among Herpes Simplex Virus Type 2-Seropositive Persons during Early HIV-1 Infection

被引：9

作者：

Kim, H. Nina ^{[1
,4
]}

Wang, Jing ^{[7
]}

Hughes, James ^{[7
]}

Coombs, Robert ^{[2
,4
,5
]}

Sanchez, Jorge ^{[11
]}

Reid, Stewart ^{[8
,12
]}

Delany-Moretlwe, Sinead ^{[13
]}

Cowan, Frances ^{[14
]}

Fuchs, Jonathan ^{[9
,11
]}

Eshleman, Susan H. ^{[10
]}

Khaki, Leila ^{[7
]}

McMahon, Moira A. ^{[10
]}

Siliciano, Robert F. ^{[10
]}

Wald, Anna ^{[4
,7
]}

Celum, Connie ^{[3
,4
,6
]}

机构：

[1] Univ Washington, Harborview Med Ctr, Sch Med, Dept Med, Seattle, WA 98104 USA

[2] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98104 USA

[3] Univ Washington, Sch Med, Dept Global Hlth, Seattle, WA 98104 USA

[4] Univ Washington, Sch Publ Hlth, Dept Med, Seattle, WA 98104 USA

[5] Univ Washington, Sch Publ Hlth, Dept Lab Med, Seattle, WA 98104 USA

[6] Univ Washington, Sch Publ Hlth, Dept Global Hlth, Seattle, WA 98104 USA

[7] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA

[8] Univ Alabama, Dept Med, Birmingham, AL 35294 USA

[9] San Francisco Dept Publ Hlth, San Francisco, CA USA

[10] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA

[11] Asociac Civil Impacta Salud & Educ IMPACTA, Lima, Peru

[12] Ctr Infect Dis Res Zambia, Lusaka, Zambia

[13] Univ Witwatersrand, Reprod Hlth Unit, Johannesburg, South Africa

[14] UCL, London, England

来源：

JOURNAL OF INFECTIOUS DISEASES | 2010年 / 202卷 / 05期

基金：

美国国家卫生研究院;

关键词：

REVERSE-TRANSCRIPTASE; SEROCONVERSION; ACQUISITION; RESISTANCE; MUTATION; COHORT; UGANDA; TRIAL; RAKAI; MEN;

D O I：

10.1086/655662

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We evaluated whether acyclovir suppression during human immunodeficiency virus type 1 (HIV-1) acquisition reduces HIV-1 set point, increases CD4 cell counts, and selects reverse-transcriptase mutations among 76 HIV-1 seroconverters identified in a placebo-controlled trial of twice-daily acyclovir (400 mg) for the prevention of HIV acquisition in herpes simplex virus type 2 (HSV-2)-seropositive persons (HIV Prevention Trials Network study 039). We found no significant difference in plasma HIV-1 RNA levels (Pp. 30) or CD4 cell counts (Pp. 85) between the acyclovir and placebo recipients. V75I and other mutations in HIV-1 reverse transcriptase reported from in vitro acyclovir studies were not observed. In conclusion, acyclovir suppression during HIV-1 seroconversion and the subsequent 6 months does not affect HIV-1 set point.

引用

页码：734 / 738

页数：5

共 50 条

[41] Herpes simplex virus chronically infected human T lymphocytes are susceptible to HIV-1 superinfection and support HIV-1 pseudotyping
Calistri, A
Parolin, C
Pizzato, M
Calvi, P
Giaretta, I
Palú, G
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 21 (02): : 90 - 98
[42] Partner Characteristics Predicting HIV-1 Set Point in Sexually Acquired HIV-1 Among African Seroconverters
Lingappa, Jairam R.
Thomas, Katherine K.
Hughes, James P.
Baeten, Jared M.
Wald, Anna
Farquhar, Carey
de Bruyn, Guy
Fife, Kenneth H.
Campbell, Mary S.
Kapiga, Saidi
Mullins, James I.
Celum, Connie
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (01) : 164 - 171
[43] MYOPATHY WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) INFECTION - HIV-1 OR ZIDOVUDINE
TILL, M
MACDONELL, KB
ANNALS OF INTERNAL MEDICINE, 1990, 113 (07) : 492 - 494
[44] Daily Acyclovir to Decrease Herpes Simplex Virus Type 2 (HSV-2) Transmission from HSV-2/HIV-1 Coinfected Persons: A Randomized Controlled Trial
Mujugira, Andrew
Magaret, Amalia S.
Celum, Connie
Baeten, Jared M.
Lingappa, Jairam R.
Morrow, Rhoda Ashley
Fife, Kenneth H.
Delany-Moretlwe, Sinead
de Bruyn, Guy
Bukusi, Elizabeth A.
Karita, Etienne
Kapiga, Saidi
Corey, Lawrence
Wald, Anna
JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (09): : 1366 - 1374
[45] Oral mucosal reactivation rates of herpesviruses among HIV-1 seropositive - persons
Griffin, Elizabeth
Krantz, Elizabeth
Selke, Stacy
Huang, Meei-Li
Wald, Anna
JOURNAL OF MEDICAL VIROLOGY, 2008, 80 (07) : 1153 - 1159
[46] Preliminary evaluation of human immunodeficiency virus type 1 (HIV-1) immunogen in children with HIV-1 infection
Sei, S
Sandelli, SL
Theofan, G
Ratto-Kim, S
Kumagai, M
Loomis-Price, LD
Cox, JH
Jarosinski, P
Walsek, CM
Brouwers, P
Venzon, DJ
Xu, J
Pizzo, PA
Moss, RB
Robb, ML
Wood, LV
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (03): : 626 - 640
[47] Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial
Lingappa, Jairam R.
Baeten, Jared M.
Wald, Anna
Hughes, James P.
Thomas, Katherine K.
Mujugira, Andrew
Mugo, Nelly
Bukusi, Elizabeth A.
Cohen, Craig R.
Katabira, Elly
Ronald, Allan
Kiarie, James
Farquhar, Carey
Stewart, Grace John
Makhema, Joseph
Essex, Myron
Were, Edwin
Fife, Kenneth H.
de Bruyn, Guy
Gray, Glenda E.
McIntyre, James A.
Manongi, Rachel
Kapiga, Saidi
Coetzee, David
Allen, Susan
Inambao, Mubiana
Kayitenkore, Kayitesi
Karita, Etienne
Kanweka, William
Delany, Sinead
Rees, Helen
Vwalika, Bellington
Magaret, Amalia S.
Wang, Richard S.
Kidoguchi, Lora
Barnes, Linda
Ridzon, Renee
Corey, Lawrence
Celum, Connie
LANCET, 2010, 375 (9717): : 824 - 833
[48] A randomised placebo-controlled trial to explore the effect of suppressive therapy with acyclovir on genital shedding of HIV-1 and herpes simplex virus type 2 among Zimbabwean sex workers
Cowan, F. M.
Pascoe, S. J.
Barlow, K. L.
Langhaug, L. F.
Jaffar, S.
Hargrove, J. W.
Robinson, N. J.
Bassett, M. T.
Wilson, D.
Brown, D. W. G.
Hayes, R. J.
SEXUALLY TRANSMITTED INFECTIONS, 2008, 84 (07) : 548 - 553
[49] Prolonged hepatitis A infection in an HIV-1 seropositive patient
Costa-Mattioli, M
Allavena, C
Poirier, AS
Billaudel, S
Raffi, F
Ferré, V
JOURNAL OF MEDICAL VIROLOGY, 2002, 68 (01) : 7 - 11
[50] Atypical presentations of genital herpes simplex virus in HIV-1 and HIV-2 effectively treated by imiquimod
McKendry, Anna
Narayana, Srinivasulu
Browne, Rita
INTERNATIONAL JOURNAL OF STD & AIDS, 2015, 26 (06) : 441 - 443

← 1 2 3 4 5 →